Caffeine and Sodium Benzoate
Medscape Medical News
The US Food and Drug Administration (FDA) has approved a new formulation of hydrocodone (Zohydro Extended Release Capsules, CII, Zogenix Inc) with abuse-deterrent properties."...
Caffeine and Sodium Benzoate Injection
CAFFEINE AND SODIUM BENZOATE INJECTION, USP (caffeine alkaloid)
Caffeine and Sodium Benzoate Injection, USP (caffeine alkaloid) is a clear, sterile, nonpyrogenic, solution of Caffeine Alkaloid.
Each mL contains: Caffeine (anhydrous) 125 mg; Sodium Benzoate (added to increase the solubility of Caffeine) 125 mg; Water for Injection, USP q.s. pH (range 6.5 to 8.5) adjusted with Hydrochloric Acid and/or Sodium Hydroxide. For intramuscular or slow intravenous administration only.
Last reviewed on RxList: 9/30/2008
This monograph has been modified to include the generic and brand name in many instances.
Additional Caffeine and Sodium Benzoate Injection Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.